Pages that link to "Q28283441"
Jump to navigation
Jump to search
The following pages link to The astrocyte in multiple sclerosis revisited (Q28283441):
Displaying 50 items.
- Astrocytes differentially respond to inflammatory autoimmune insults and imbalances of neural activity (Q22001061) (← links)
- The Role of Astrocytes in Multiple Sclerosis Progression (Q26782843) (← links)
- Fingolimod for the treatment of neurological diseases-state of play and future perspectives (Q27026175) (← links)
- KIR4.1: K+ Channel Illusion or Reality in the Autoimmune Pathogenesis of Multiple Sclerosis (Q28071531) (← links)
- The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis (Q28073377) (← links)
- The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis (Q28076400) (← links)
- Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes (Q28078621) (← links)
- HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads (Q28392199) (← links)
- Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis (Q30871249) (← links)
- 11C-acetate PET imaging in patients with multiple sclerosis (Q34450336) (← links)
- Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration (Q34463760) (← links)
- Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis (Q34720644) (← links)
- Regulation of neurovascular coupling in autoimmunity to water and ion channels (Q35001946) (← links)
- Chemokine CXCL8 promotes HIV-1 replication in human monocyte-derived macrophages and primary microglia via nuclear factor-κB pathway. (Q35129108) (← links)
- Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter (Q35193921) (← links)
- Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes (Q35780751) (← links)
- Utility of a Multiparametric Quantitative MRI Model That Assesses Myelin and Edema for Evaluating Plaques, Periplaque White Matter, and Normal-Appearing White Matter in Patients with Multiple Sclerosis: A Feasibility Study. (Q36176657) (← links)
- Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis (Q36298402) (← links)
- PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption (Q36356190) (← links)
- Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology? (Q37478957) (← links)
- Multiple sclerosis: experimental models and reality (Q37596784) (← links)
- Astrocyte barriers to neurotoxic inflammation (Q37597818) (← links)
- Astrocyte-derived endothelin-1 inhibits remyelination through notch activation (Q37604029) (← links)
- Teriflunomide and its mechanism of action in multiple sclerosis (Q37730005) (← links)
- MicroRNAs and multiple sclerosis: from physiopathology toward therapy (Q38140046) (← links)
- Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators (Q38150821) (← links)
- Mechanisms of white matter damage in multiple sclerosis (Q38182524) (← links)
- Rising stars: modulation of brain functions by astroglial type-1 cannabinoid receptors (Q38276026) (← links)
- Glial regulation of the blood-brain barrier in health and disease. (Q38561270) (← links)
- Progressive MS: from pathophysiology to drug discovery (Q38585418) (← links)
- Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion (Q38669047) (← links)
- Sodium channels in astroglia and microglia (Q38751614) (← links)
- Astrocytes in multiple sclerosis. (Q38840390) (← links)
- Direct immunomodulatory influence of IFN-β on human astrocytoma cells (Q38908710) (← links)
- Neurodegeneration in multiple sclerosis and neuromyelitis optica (Q38965274) (← links)
- Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology (Q39070347) (← links)
- Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis. (Q39167264) (← links)
- Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis (Q41594953) (← links)
- Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation. (Q42234408) (← links)
- Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response (Q42685267) (← links)
- Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination (Q43865165) (← links)
- Modulation of P2X7 Receptor during Inflammation in Multiple Sclerosis. (Q46030490) (← links)
- RGC-32 Promotes Th17 Cell Differentiation and Enhances Experimental Autoimmune Encephalomyelitis. (Q47930819) (← links)
- Inflammatory demyelinating diseases of the central nervous system (Q48029570) (← links)
- Calibrated imaging reveals altered grey matter metabolism related to white matter microstructure and symptom severity in multiple sclerosis (Q48151201) (← links)
- Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes. (Q49568258) (← links)
- Preserved canonicality of the BOLD hemodynamic response reflects healthy cognition: Insights into the healthy brain through the window of multiple sclerosis. (Q49895304) (← links)
- Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis (Q50103105) (← links)
- The Role of Astrocytes in Multiple Sclerosis. (Q52668332) (← links)
- MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3/STAT3 signaling (Q57182670) (← links)